A nimal models 1 and twin studies 2 suggest that genes influence susceptibility to ischemic stroke, and there are some rare Mendelian stroke syndromes in man. 3, 4 Polymorphisms in 2 genes have been associated recently with stroke in Iceland, 5, 6 but the observations have yet to be reproduced elsewhere and their mechanisms determined. Results of previous candidate gene studies have been inconsistent, and positive associations have not been reproduced. 3, 7, 8 Interpretation of molecular genetic studies in ischemic stroke is also undermined by a lack of reliable data on the genetic epidemiology. 2, 3 For example, it is uncertain how heritability of stroke is associated with intermediate phenotypes (IPs), such as large artery atherosclerosis and hypertension, which both have substantial genetic components, 9 and could be confounders in molecular genetic studies.
In the absence of detailed twin studies, family history (FHx) studies can provide useful data on the heritability of stroke. 2, 3 Several prospective cohort studies have been reported 2, 3 but have provided little detail on IPs. Case control studies are difficult to interpret because of recall bias, and few have taken account of the subtype of stroke, age of the proband or of the affected first-degree relative (FDR), the number of affected FDRs, and sibship size. 2, 3 An alternative approach is to do case-to-case studies (ie, to compare the characteristics of patients with versus without FHx). This methodology avoids recall bias inherent in case control comparisons because all patients have experienced a recent cerebrovascular event and can determine which characteristics of the proband (eg, age, subtype, IPs, etc) are associated with FHx. A study confined to transient ischemic attack (TIA) patients avoids other biases resulting from unavailability of data in stroke patients with dysphasia, intercurrent illness, or cognitive dysfunction, and is less liable to bias because of changes in measurements of IPs, such as blood pressure (BP), cholesterol, and glucose, caused by the acute event itself.
We investigated the relationships of FHx of stroke (FHx stroke ) and FHx of myocardial infarction (FHx MI ), including age of the proband, the FDRs affected, and the number of affected FDRs, with clinical characteristics and IPs in 2 population-based incidence studies and 2 prospective consecutive hospital-referred series of patients with a recent TIA.
Methods
The population-based studies conformed to the standard quality criteria for stroke incidence studies. 10, 11 The methods and results of the Oxfordshire Community Stroke Project (OCSP) 12 have been published previously. 13, 14 The ongoing Oxford Vascular Study (OXVASC) used identical methods of ascertainment to the OCSP. 14, 15 The methods of the Oxford hospital-referred TIA patient series have also been published previously. 16 Briefly, a consecutive cohort of patients with cerebral or ocular TIA without previous stroke was assembled prospectively by a vascular neurologist between 1976 and 1986. We also collected data from all TIA patients seen at 3 dedicated TIA clinics in Oxford from 2002 to 2003. Researchers used a structured questionnaire to prospectively record clinical data. Studies were approved by the local ethics committee.
In all studies, a study neurologist assessed patients as soon as possible after notification and computed tomography brain imaging was obtained. A TIA was defined as an episode of sudden-onset focal neurological disturbance, presumed to be vascular in origin, with symptoms lasting Ͻ24 hours. Details of the presenting event, clinical characteristics, and medical history were recorded from the patient, relatives, family practitioner (FP), and hospital records.
Family History
FHx was collected using a semistructured (OCSP) or structured questionnaire (OXVASC and both hospital-based TIA series) separately for stroke and for myocardial infarction (MI) from the patients, their relatives, and their medical records. It was regarded as positive if Ն1 FDR was affected. All cohorts recorded whether father, mother, or siblings were affected. The number of affected FDRs and their relationship to the proband were recorded. Family trees and details of what age the relative was when affected and the overall number of siblings were collected in OXVASC and the second hospital-referred series. The assessment of the history of stroke in an FDR was based on the patient's or relative's description. Histories of TIA, intracranial hemorrhage, or subarachnoid hemorrhage were excluded. The definition of MI in an FDR was also based on the clinical description and included sudden death. Previous work has shown that nonverified patient-reported FHx in FDRs is sometimes inaccurate but that the likelihood ratios for FHx stroke and FHx MI are 11.2 (95% CI, 9.2 to 13.6) and 8.6 (95% CI, 6.8 to 10.9), respectively, indicating good discriminatory power. 17 
Baseline Data
Detailed baseline data were recorded, including age, sex, systolic BP (SBP), and diastolic BP (DBP; measured at the initial interview). The highest-ever premorbid SBP and DBP and the most recent BP predating the TIA were obtained from FP records in both populationbased studies. Information on the following medical conditions before the TIA was obtained from patients or their medical records: previous ischemic heart disease (IHD; angina or MI), hypertension (on medication), cardiac failure (on medication), diabetes mellitus (DM; on medication), and peripheral vascular disease. Patients were classified as current smokers if they were smoking at the time of assessments or had given up smoking Ͻ1 year previously. The following information was recorded about the presenting event: carotid versus vertebrobasilar territory, cerebral versus ocular only (if carotid territory), and duration of longest event. Nonfasting blood was sampled for packed-cell volume, platelet count, erythrocyte sedimentation rate (ESR), and for random total cholesterol, triglyceride, and plasma glucose.
Statistical Analysis
Heterogeneity of associations between studies was calculated with the 2 method. Where appropriate, data were pooled to increase statistical power. We allowed for possible differences between studies by adjusting or stratifying analyses by "study" where appropriate. We also calculated odds ratios (ORs) within individual studies and combined them by fixed-effects meta-analysis using the Mantel-Haenszel method. To study any differences in baseline characteristics between patients with and without FHx, we used the 2 test for categorical variables. If a cell contained an expected number of Յ5, we used a 2-tailed Fisher exact test. We used ANOVA for comparison of continuous variables. For any factor that showed an association with FHx, we performed a logistic regression analysis, adjusting for age, sex, study, and the presence of other vascular risk factors. All analyses were performed with SPSS version 12.0.1 (SPSS).
Results
Of 184 patients with a TIA in OCSP, FHx was available in 178 (96.7%). Of the first 130 patients with a TIA in OXVASC, FHx was available in 124 (95.4%). Of 469 patients from the first Oxford hospital-referred series, FHx was available in 391 patients after exclusion of patients who were also enrolled in the OCSP. The second Oxford hospitalreferred series recruited 95 consecutive patients; FHx was There were no significant differences between populationbased and hospital-referred cohorts in the frequency of FHx or in which FDRs were affected (Table 1) , nor in age, sex, or other risk factors. Furthermore, the age at which relatives were affected, as well as the total number of siblings, was similarly distributed in both cohorts (OXVASC; and second hospital-referred series) that collected these data. For the following analyses, we therefore report results from the pooled data of all 4 cohorts where appropriate. An FHx stroke was less common (189 patients; 24.1%) than an FHx MI (254 patients; 32.4%; Pϭ0.0003). FHx of both MI and stroke was present in 67 (8.6%), whereas 376 (48.0%) had FHx of either stroke or MI. Thirty-five (4.5%) had Ͼ1 affected FDR with stroke, and 73 (9.3%) had multiple affected FDRs with MI. Age did not differ significantly between patients with and without FHx stroke or FHx MI .
A total of 185 patients had an ocular TIA only, with no history of recent cerebral ischemia, and 437 patients had a recent cerebral carotid territory TIA. FHx stroke was less common in cases with an ocular TIA only than in cases with cerebral events (20.6% versus 32.8%; OR, 0.53; 95% CI, 0.34 to 0.82; Pϭ0.004). However, this association was no longer significant after adjustment for history of hypertension and source study (OR, 0.66; 95% CI, 0.41 to 1.05; Pϭ0.08), but was changed little by further adjustment for age, sex, DM, IHD, and smoking (OR, 0.67; 95% CI, 0.42 to 1.08; Pϭ0.10). FHx stroke did not differ between patients with carotid or vertebrobasilar TIA or in relation to TIA duration. FHx MI showed no significant association with TIA territory (Table 2) .
Patients with FHx stroke were more likely to have a history of hypertension than those without (56.1% versus 41.2%; OR, 1.78; 95% CI, 1.28 to 2.48; Pϭ0.0008; Table 3 ) with no significant heterogeneity between the cohorts (Pϭ0.66; Figure) . The association remained highly significant after multivariate adjustment for study, age, sex, DM, and smoking (OR, 1.66; 95% CI, 1.18 to 2.33; Pϭ0.003). There was also a trend for higher mean SBP and DBP in patients with FHx stroke (Table 3) , particularly in the 2 older studies, which were performed when antihypertensive treatment was less (Table 3) . FHx MI was strongly associated with a history of IHD in the proband (OR, 1.98; 95% CI, 1.39 to 2.83; Pϭ0.0002). In contrast, there was no association with FHx stroke and IHD (OR, 0.97; 95% CI, 0.65 to 1.46; Pϭ0.90). Neither FHx was associated with a history of peripheral vascular disease, cardiac failure, DM, atrial fibrillation, or current smoking after adjusting for source study (Table 2) .
There was no association between FHx stroke or FHx MI and total cholesterol, mean glucose, packed-cell volume, platelets, or ESR. However, FHx MI was associated with higher mean triglyceride levels (1.90 versus 1.74 mmol/L; Pϭ0.05). However, this association was no longer significant after multivariate adjustment for study, age, sex, DM, hypertension, and smoking. FHx stroke showed no association with triglyceride levels (Table 2) .
Discussion
This study is the largest published report examining FHx in patients with TIA. Our combined cohort is nearly 10ϫ larger than the only previous published study. 18 Our results were generally consistent across the 2 population-based studies and 2 hospital-referred series. We found associations between FHx stroke and personal history of hypertension and actual measurements of BP, particularly in the population-based studies, in which data on premorbid BP were available. We also found some interesting differences between patients with FHx stroke versus FHx MI in the presence of other vascular risk factors. Because we confined our comparisons to TIA patients rather than patients versus controls, our findings are unlikely to be undermined by recall bias. We also reported data on the frequency of multiple affected FDRs, which are useful in the planning of linkage-based genetic studies, such as affected sibling pair studies.
The association between FHx stroke and hypertension is important because BP is the single most powerful risk factor for stroke 19, 20 and has a strong heritable component itself. 21 The corresponding associations between FHx stroke and measured BP are likely to be underestimates of the true associations because of intraindividual variation in BP and consequent regression dilution of associations based on single measurements. 22 The observed relationships will also have been weakened by treatment of hypertension, which would 
Flossmann and Rothwell Hypertension and Stroke Family History in TIA Patients
explain why the association between FHx stroke and BP was stronger for the highest-ever recorded premorbid measurement than for the most recent measurement. Hypertension was also associated with FHx MI , but measured levels of BP had a weaker correlation compared with FHx stroke . We have shown previously that FHx stroke but not FHx MI was linked with a history of hypertension in stroke patients. 23 These associations between hypertension and FHx stroke could reflect familial clustering of hypertension attributable to either shared genetic or environmental factors. 24 Virtually all IHD and many ischemic strokes are manifestations of atherosclerotic vascular disease and share common risk factors. This close relationship is further highlighted by the fact that even in our patients with TIA, FHx MI was more prevalent than FHx stroke . However, there were important differences in the prevalence of IPs between TIA patients with FHx MI versus those with FHx stroke . Only FHx MI was significantly associated with a previous diagnosis of IHD and with higher mean triglyceride levels. Neither FHx correlated with a previous diagnosis of DM or serum glucose. This is consistent with previous studies in stroke patients. 2 Although patients with ocular TIA(s) only were just as likely as patients with cerebral TIAs to have FHx MI , indicating a possible heritability of large vessel atherosclerosis , they were less likely to have FHx stroke. This suggests perhaps that genetic factors are involved in cerebral susceptibility to ischemia, given the lower risk of stroke associated with ocular TIAs. However, the association was diminished and was no longer statistically significant after adjustment for hypertension.
Our study had some shortcomings. First, in common with most other published studies of the genetic epidemiology of stroke, details of the FHx were limited. Not all of our studies recorded the age at which stroke or MI occurred in the relative, and we had no information on the subtype of stroke in the FDR. In particular, we were not able to reliably distinguish between ischemic and hemorrhagic stroke in FDRs because many of their strokes predated routine brain imaging. Nevertheless, although this limited our analyses to some extent, it is unlikely to have led to any systematic bias because hypertension has a similarly strong association with ischemic and hemorrhagic stroke. 25 Therefore, it is unlikely that the confounding of heritability by hypertension we found is accounted for by inclusion of some FDR with hemorrhagic stroke. Second, although we used FHx as a possible indicator for genetic influences, familial clustering of a disease can also be attributable to a shared environment. Third, it is possible that patients with FHx were more likely to have had health screening before their TIA than patients without FHx. However, this would be true for FHx stroke and FHx MI . Therefore, it is unlikely that the strong association of FHx stroke but not FHx MI with highest-ever BP is accounted for by this potential bias. Finally, the lack of significant heterogeneity between the studies could reflect the comparatively small size of each individual cohort.
In conclusion, we found a strong association between FHx stroke , history of hypertension, and maximum recorded premorbid BPs. In contrast to FHx MI , there was no association between FHx stroke and history of IHD or triglyceride level in the proband. Of the established IPs, our findings suggest that heritability of BP is the most important contributor to heritability of stroke. Candidate gene studies should adjust for differences in measured BP, history of hypertension, and treatment of hypertension between cases and controls.
